| Literature DB >> 33052953 |
Lijun Lu1, Eric S Loker1, Coen M Adema1, Si-Ming Zhang1, Lijing Bu1.
Abstract
Achieving a deeper understanding of the factors controlling the defense responses of invertebrate vectors to the human-infecting pathogens they transmit will provide needed new leads to pursue for control. Consequently, we provide new genomic and transcriptomic insights regarding FReDs (containing a fibrinogen domain) and FREPs (fibrinogen domain and one or two IgSF domains) from the planorbid snail Biomphalaria glabrata, a Neotropical vector of Schistosoma mansoni, causative agent of human intestinal schistosomiasis. Using new bioinformatics approaches to improve annotation applied to both genome and RNA-Seq data, we identify 73 FReD genes, 39 of which are FREPs. We provide details of domain structure and consider relationships and homologies of B. glabrata FBG and IgSF domains. We note that schistosome-resistant (BS-90) snails mount complex FREP responses following exposure to S. mansoni infection whereas schistosome-susceptible (M line) snails do not. We also identify several coding differences between BS-90 and M line snails in three FREPs (2, 3.1 and 3.2) repeatedly implicated in other studies of anti-schistosome responses. In combination with other results, our study provides a strong impetus to pursue particular FREPs (2, 3.1, 3.2 and 4) as candidate resistance factors to be considered more broadly with respect to schistosome control efforts, including involving other Biomphalaria species vectoring S. mansoni in endemic areas in Africa.Entities:
Mesh:
Substances:
Year: 2020 PMID: 33052953 PMCID: PMC7588048 DOI: 10.1371/journal.pntd.0008780
Source DB: PubMed Journal: PLoS Negl Trop Dis ISSN: 1935-2727
Fig 1Some relevant abbreviations used in this paper.
Detailed domain sturcture for each abbreviation can be found in Fig 3. FBG: fibrinogen domain; EGF-like: epidermal growth factor (EGF)-like domain; IgSF1: Immunoglobulin Superfamily Member 1; IgSF2: Immunoglobulin Superfamily Member 2; ICR: interceding region (<150aa) between IgSF and FBG domains that form coiled coils; long ICR: long interceding region (150~320aa).
Fig 3Predicted domain architectures of FReD proteins in B. glabrata BB02.
Three main categories are indicated: sFReD (FBG), FReM (EGF-like + FBG), 1-IgSF FREP (1 IgSF loop + FBG), and 2-IgSF FREP (2 IgSF loops + FBG). FBG: fibrinogen domain; EGF-like: epidermal growth factor (EGF)-like domain; PAN/Apple: PAN/Apple domain; IgSF1: Immunoglobulin Superfamily Member 1; IgSF2: Immunoglobulin Superfamily Member 2; ICR: interceding region (<150aa) between IgSF and FBG domains that form coiled coils; long ICR: long interceding region (150~320aa).
Fig 2Workflow to predict FBG and IgSF domains in the genome assembly of BB02 B. glabrata.
The colored boxes highlight some of the important steps/results in the workflow.
Summary of 39 FREPs discussed in this study.
| Previously reported FREPs | Newly identified FREPs | Total | |||
|---|---|---|---|---|---|
| 1-IgSF | 2-IgSFs | 1-IgSF | 2-IgSFs | ||
| Complete | 6 | 19 | 1 | 0 | |
| Partial | 1 | 6 | 4 | 2 | |
| Total | |||||
*: Some previously published FREPs were extended in this study as complete FREPs.
Summary of predicted FReD proteins in B. glabrata BB02 strain.
| ID in text | NCBI annotation | Type of FReD | Best hit to published FREP |
|---|---|---|---|
| Bg11-PA | Fibrinogen-like protein A, partial | partial 1-IgSF FREP | 11_sig_1434_BGLB000011 |
| IBg11-PB | Fibrinogen-like protein A, partial | 1-IgSF FREP | 11_sig_1434_BGLB000011 |
| Bg19-PA | Fibrinogen C domain-containing protein 1-B-like | 2-IgSF FREP | FREP5 |
| Bg19-PB | Fibrinogen C domain-containing protein 1-B-like | 2-IgSF FREP | FREP5 |
| Bg21-PA | Fibroleukin-like | partial 2-IgSF FREP | 17_tig_2702_BGLB000021 |
| Bg21-PB | Fibroleukin-like | 2-IgSF FREP | 17_tig_2702_BGLB000021 |
| Bg74-PA | Uncharacterized protein LOC106071720, partial | partial 2-IgSF FREP | FREPJ4 |
| Bg74-PB | Uncharacterized protein LOC106071720, partial | partial 2-IgSF FREP | FREPJ4 |
| Bg96-PA | Fibroleukin-like | 2-IgSF FREP | FREP3.1 |
| Bg96-PB | Fibroleukin-like | 2-IgSF FREP | FREP3.1 |
| Bg100-PA | Angiopoietin-4-like | 2-IgSF FREP | 14_tig_2094_BGLB000100 |
| Bg100-PB | Angiopoietin-4-like | 2-IgSF FREP | 14_tig_2094_BGLB000100 |
| Bg116-PA | Uncharacterized protein LOC106057350 | 2-IgSF FREP | 1_tig_99_BGLB000116 |
| Bg116-PB | Uncharacterized protein LOC106057350 | 2-IgSF FREP | 1_tig_99_BGLB000116 |
| Bg131-PA | --- | partial 2-IgSF FREP | z_tig_6870_frameshifts |
| Bg133-PA | Angiopoietin-2-like | 2-IgSF FREP | 22_tig_4104_BGLB000133 |
| Bg133-PB | Angiopoietin-2-like | 2-IgSF FREP | 22_tig_4104_BGLB000133 |
| Bg140-PA | Fibroleukin-like | 2-IgSF FREP | FREP13.1 |
| Bg140-PB | Fibroleukin-like | 2-IgSF FREP | FREP13.1 |
| Bg141-PA | Fibrinogen-like protein A | 1-IgSF FREP | FREPA |
| Bg141-PB | Fibrinogen-like protein A | 1-IgSF FREP | FREPA |
| Bg152-PA | Fibrinogen C domain-containing protein 1-like | 1-IgSF FREP | FREP4 |
| Bg152-PB | Fibrinogen C domain-containing protein 1-like | 1-IgSF FREP | FREP4 |
| Bg179-PA | Fibrinogen beta chain-like | 1-IgSF FREP | FREP1 |
| Bg179-PB | Fibrinogen beta chain-like | partial 1-IgSF FREP | FREP1 |
| Bg204-PB | Tenascin-R-like | 2-IgSF FREP | FREP3.2 |
| Bg4529-PB | Uncharacterized protein LOC106059401 | 2-IgSF FREP | FREP7-like |
| Bg4530-PB | Fibrinogen C domain-containing protein 1-B-like | 2-IgSF FREP | FREPJ2-like |
| Bg5224-PA | Uncharacterized protein LOC106061038 | partial 2-IgSF FREP | FREPJ5 |
| Bg5224-PB | Uncharacterized protein LOC106061038 | 2-IgSF FREP | FREPJ5 |
| Bg6034-PB | Uncharacterized protein LOC106062908 | partial 2-IgSF FREP | FREP12.1-as2-like |
| Bg7076-PB | Angiopoietin-related protein 2-like | 2-IgSF FREP | 4_tig_565_BGLB000073-like |
| Bg7576-PB | Uncharacterized protein LOC106066900 isoform X2 | 2-IgSF FREP | FREPM |
| Bg7576-PC | Uncharacterized protein LOC106066900 isoform X1 | 2-IgSF FREP | FREPM |
| Bg10948-PB | Uncharacterized protein LOC106074953 | partial 2-IgSF FREP | FREPK1 |
| Bg11626-PA | Angiopoietin-related protein 2-like | partial 2-IgSF FREP | FREP12-like |
| Bg11626-PB | Angiopoietin-related protein 2-like | 2-IgSF FREP | FREP12-like |
| Bg11627-PA | Angiopoietin-related protein 2-like | partial 1-IgSF FREP | 5_tig_565_BGLB011626 |
| Bg11627-PB | Angiopoietin-related protein 2-like | 2-IgSF FREP | 5_tig_565_BGLB011626 |
| Bg14428-PB | Ryncolin-4-like | 1-IgSF FREP | FREP14 |
| Bg16934-PA | Fibrinogen beta chain-like | 2-IgSF FREP | 20_tig_3569_BGLB009245b |
| Bg16935-PA | Angiopoietin-4-like | 2-IgSF FREP | 19_tig_3569_BGLB009245a |
| Bg17688-PA | Fibrinogen beta chain-like | 2-IgSF FREP | zb_tig_15796 |
| Bg17893-PA | Uncharacterized protein LOC106053933 | 2-IgSF FREP | 6_tig_990_BGLB014388 |
| Bg20516-PA* | Fibrinogen C domain-containing protein 1-like | partial 2-IgSF FREP | new partial FREP |
| Bg22646-PA | Fibrinogen C domain-containing protein 1-B-like, partial | partial 1-IgSF FREP | new partial FREP |
| Bg23857-PA | Fibrinogen C domain-containing protein 1-like, partial | partial 1-IgSF FREP | new partial FREP |
| Bg25144-PA* | Ficolin-1-like | partial 2-IgSF FREP | new partial FREP |
| Bg25334-PA | Fibrinogen C domain-containing protein 1-like | partial 1-IgSF FREP | FREPJ5 |
| Bg28617-PA | Fibrinogen-like protein A | 1-IgSF FREP | FREP2 |
| Bg29167-PA | Tenascin-like | partial 1-IgSF FREP | new partial FREP |
| Bg32905-PA* | Ficolin-2-like | partial 2-IgSF FREP | FREPJ1 |
| Bg38205-PA | Angiopoietin-4-like | partial 1-IgSF FREP | new partial FREP |
| Bg40226-PA* | Techylectin-like protein | Partial 2-IgSF FREP | FREPJ3-like |
| Bg40228-PA | Fibroleukin-like | 1-IgSF FREP | new FREP |
| Bg177-PA | Microfibril-associated glycoprotein 4-like | sFReD | |
| Bg177-PB | Microfibril-associated glycoprotein 4-like | sFReD | |
| Bg178-PA | Fibrinogen C domain-containing protein 1-like | sFReD | |
| Bg178-PB | Fibrinogen C domain-containing protein 1-like | sFReD | |
| Bg2450-PB | Ryncolin-1-like | sFReD | |
| Bg2494-PB | Ficolin-2-like isoform X1 | sFReD | |
| Bg2494-PC | Ficolin-1-like isoform X3 | sFReD | |
| Bg2494-PD | Ficolin-2-like isoform X2 | sFReD | |
| Bg2494-PE | Ficolin-1-like isoform X4 | partial sFReD | |
| Bg5196-PB | Angiopoietin-related protein 1-like | partial sFReD | |
| Bg12039-PB | Ficolin-1-like, partial | partial sFReD | |
| Bg12226-PB | Techylectin-5B-like | partial sFReD | |
| Bg12382-PB | Angiopoietin-4-like | partial sFReD | |
| Bg14428-PA | Ryncolin-4-like precursor | partial sFReD | FREP14 |
| Bg16307-PA | Ficolin-2-like | sFReD | |
| Bg16436-PA | Angiopoietin-related protein 6-like | partial sFReD | |
| Bg17041-PA | Fibrinogen C domain-containing protein 1-like | sFReD | |
| Bg17605-PA | Ficolin-2-like | sFReD | |
| Bg18336-PA | Fibrinogen-like protein A | sFReD | za_tig_4714 |
| Bg20351-PA | Ficolin-2-like | sFReD | BgMFREP4_AY012701-like |
| Bg21912-PA | Ficolin-2-like | sFReD | |
| Bg22867-PA | Fibrinogen beta chain-like, partial | partial sFReD | |
| Bg25627-PA | Ficolin-1-like | partial sFReD | |
| Bg25643-PA | Microfibril-associated glycoprotein 4-like | sFReD | |
| Bg28385-PA | Ficolin-2-like | sFReD | |
| Bg29288-PA | Uncharacterized protein LOC106051237 | partial sFReD | |
| Bg30478-PA | Fibroleukin-like, partial | partial sFReD | |
| Bg30830-PA | Ryncolin-1-like, partial | partial sFReD | |
| Bg31381-PA | Ficolin-1-like | sFReD | |
| Bg31596-PA | Angiopoietin-related protein 6-like, partial | partial sFReD | |
| Bg34525-PA | Techylectin-5A-like | partial sFReD | |
| Bg36251-PA | Ficolin-2-like | sFReD | |
| Bg37621-PA | Angiopoietin-1-like | partial sFReD | |
| Bg38117-PA | Fibrinogen C domain-containing protein 1-like, partial | partial sFReD | |
| Bg38186-PA | Ficolin-1-like | sFReD | |
| Bg38723-PA | Ficolin-1-like | sFReD | |
| Bg39918-PA | Ficolin-2-like | sFReD | |
| Bg40034-PA | Ficolin-1-like, partial | partial sFReD | 16_tig_2402_BGLB007591-like |
| Bg40339-PB | Ficolin-2-like | sFReD | |
| Bg40437-PA | Uncharacterized protein LOC106061221 | partial FReM | FReM |
For readability, the dashed lines in Table 2 separate the three types of FReDs: FREP, sFReD, or FReM.
Notes:
In the column of “ID in text”, multiple proteins encoded by the same gene due to alternative splicing were differentiated by different version of protein, such as “-PA”, “-PB”, “-PC”, “-PD” or “-PE” suffix following the gene ID;
In the column of “NCBI Annotation”, “---” represents no available annotation for a particular protein;
In the column of “Type of FReD”, each particular FReD was considered as complete or partial based on the criteria set in this study above; “1-IgSF FREP” and “2-IgSF FREP” represent the number of IgSF domains present in a particular FREP;
“Best hit to published FREP” represent the best hit of individual protein against published B. glabrata FREP sequences from available sources [30,32–34]: best hit of protein sequence identity ≥90% is considered as the same FREP; identity 85~90% is considered as “-like” of the corresponding FREP; identity <85% is not assigned to any known FREP.
In the “Best hit to published FREP” column, several FREPs were emphasized in this study were highlighted in yellow.
Fig 4Gene tree and representative protein domain architecture of 73 B. glabrata FReDs.
A. Maximum likelihood tree with 1000 bootstrap tests was constructed using full length representative protein sequences of 73 FReD genes in B. glabrata. Nodes with bootstrap support of 75 or higher are marked with black squares. The gene IDs of the 73 FReDs were followed with number of IgSF domains and the best hit with any published FREP genes (BLASTp hit with at least 150 aa aligned with ≥ 90% identity was considered as the same FREP; or considered a “FREP-like” gene if identity was 85% ~ 90%; identity <85% was not assigned to any published FREP). Any FReD genes with best hit to FREPs from the genome paper [32] are labeled with a red dot at the corresponding gene ID. Complete FREP or FReD genes fitting the criteria in this study were highlighted in blue text. B. Domain architectures were predicted using InterProScan and lineage specific HMM models. “Peptide sequences” represent multiple peptide sequences extracted from a proteomics study [49]. Colored small horizontal bars above or below some protein domain structures highlight the matched location of peptide sequences with binding affinity to S. mansoni sporocyst membrane-enriched and larval transformation proteins, from either schistosome-susceptible NMRI strain (SUS in green) or -resistant BS-90 strain (RES in red) of B. glabrata. The dashed gray line was manually added to distinguish most “sFReD clades” from “FREP clades”.
Fig 5Violin plots of protein sequence-pairwise identity analyses of IgSF1, IgSF2, and FBG domains in B. glabrata FReD genes.
The 26 complete FREP protein sequences, and complete FBG domain sequences from all FReD genes in B. glabrata were used for pairwise blast identity analysis. Number under each Violin plot at x-axis is the number used for each assigned analysis, and y-axis represents percentage of protein sequence identity (%).
Fig 6Domain tree comparisons of IgSF1, IgSF2 and FBG domains from complete 2-IgSF FREPs in B. glabrata. A.
Domain structure of 2-IgSF FREPs; B. Tree distances were measured by Robinson-Foulds or symmetric distance among trees of IgSF1, IgSF2 and FBG domains from 2-IgSF FREPs; C. Tanglegram plot of a side by side ML (Maximum Likelihood) trees for IgSF1 and IgSF2 domains from 2-IgSF FREPs; D. Tanglegram plot of ML trees for IgSF1 and FBG domains from the 2-IgSF FREPs; E. Tanglegram plot of ML trees for IgSF2 and FBG domains from the 2-IgSF FREPs. The colored connection lines in 6C, 6D and 6E highlighted some common subtrees.
Fig 7Unrooted Maximum Likelihood (ML) trees of IgSF domains identified in B. glabrata with new HMM profile search.
A: ML tree with all IgSF domains from search using the 38 new IgSF HMM profiles (in Fig 2). Gray branches in panel A represent other IgSFs predicted with 36 new HMM profiles, which are not associated with FBG domain; B: An ML tree for only IgSF1 and IgSF2 domains from B. glabrata. ML trees with 1000 bootstrap tests were constructed using IQ-TREE. Nodes with bootstrap support of 75 or higher were highlighted with black squares at the nodes in panel B. Any domains associated with FBG domain are colored in red (IgSF1) or in blue (IgSF2) and followed with name of best hit to published FREPs. IgSF1 or IgSF2 domains without association with FBG domain are colored in pink (IgSF1) or in light blue (IgSF2). Gene has been identified previously in the genome paper [32] is labelled with an asterisk next to the corresponding gene ID. 1-IgSF FREPs are labeled with a green dot at the end of the branches. All FREPs identified in this study were named with IgSF domain, the Vectorbase ID and the best hit to published FREPs.
Summary of expression levels of FReD genes in RES and SUS B. glabrata: Constitutive and post-exposure responses to S. mansoni.
| ID in text | Unexposed RES vs. Unexposed SUS | RES exposed to | SUS exposed to | Type of FReD | Best hit to known FREP | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 0.5d | 2d | 40d | 0.5d | 2d | 8d | 40d | 0.5d | 2d | 8d | 40d | |||
| Bg11 | ns | ns | ns | 1.31 | ns | 1 | ns | ns | ns | ns | ns | 1-IgSF FREP | 11_sig_1434_BGLB000011 |
| Bg19 | ns | ns | -2.16 | ns | ns | ns | ns | ns | ns | ns | ns | 2-IgSF FREP | FREP5 |
| Bg74 | ns | 1.51 | ns | ns | ns | ns | ns | ns | ns | ns | ns | partial 2-IgSF FREP | FREPJ4 |
| Bg96 | ns | 1.06 | ns | ns | 1.86 | 1.09 | ns | ns | ns | ns | ns | 2-IgSF FREP | FREP3.1 |
| Bg116 | ns | -2.11 | ns | 1.95 | 3.64 | ns | ns | ns | ns | ns | ns | 2-IgSF FREP | 1_tig_99_BGLB000116 |
| Bg131 | ns | -1.74 | -2.52 | ns | ns | ns | ns | ns | ns | ns | ns | partial 2-IgSF FREP | z_tig_6870_frameshifts |
| Bg133 | 1.8 | ns | ns | ns | ns | ns | ns | ns | ns | ns | ns | 2-IgSF FREP | 22_tig_4104_BGLB000133 |
| Bg141 | ns | ns | 3.18 | ns | ns | ns | ns | ns | ns | ns | ns | 1-IgSF FREP | FREPA |
| Bg152 | ns | ns | ns | 2.93 | 9.18 | 4.91 | 3.37 | -5.59 | ns | ns | ns | 1-IgSF FREP | FREP4 |
| Bg204 | -2.1 | -2.58 | -3.15 | 1.94 | 3.09 | ns | ns | ns | ns | ns | ns | 2-IgSF FREP | FREP3.2 |
| Bg4529 | ns | -1.06 | ns | ns | 1.07 | ns | ns | ns | ns | ns | ns | 2-IgSF FREP | FREP7-like |
| Bg4530 | ns | -2.79 | -3.88 | ns | 2.59 | ns | ns | ns | ns | ns | ns | 2-IgSF FREP | FREPJ2-like |
| Bg5224 | ns | 1.24 | ns | 1.13 | 1.45 | ns | ns | ns | ns | ns | ns | 2-IgSF FREP | FREPJ5 |
| Bg6034 | ns | -1.19 | ns | ns | 3.64 | ns | ns | ns | ns | ns | ns | partial 2-IgSF FREP | FREP12.1-as2-like |
| Bg14428 | ns | ns | -1.11 | 1.05 | ns | ns | ns | ns | ns | ns | ns | 1-IgSF FREP | FREP14 |
| Bg16934 | ns | ns | -5.41 | ns | ns | ns | ns | ns | ns | ns | -6.42 | 2-IgSF FREP | 20_tig_3569_BGLB009245b |
| Bg16935 | 1.04 | ns | ns | ns | ns | ns | ns | ns | ns | ns | ns | 2-IgSF FREP | 19_tig_3569_BGLB009245a |
| Bg17688 | ns | ns | -2.74 | ns | ns | ns | ns | ns | ns | ns | ns | 2-IgSF FREP | zb_tig_15796 |
| Bg20516* | 8.96 | ns | ns | ns | 6.79 | 4.84 | ns | ns | ns | ns | ns | partial 2-IgSF FREP | new partial FREP |
| Bg22646 | ns | ns | ns | ns | 1.1 | ns | ns | ns | ns | ns | ns | partial 1-IgSF FREP | new partial FREP |
| Bg23857 | ns | -2.33 | -2.53 | 1.4 | 2.42 | ns | ns | ns | ns | ns | ns | partial 1-IgSF FREP | new partial FREP |
| Bg25144* | ns | ns | ns | ns | 1.44 | ns | ns | ns | ns | ns | ns | partial 2-IgSF FREP | new partial FREP |
| Bg25334 | 4.4 | 4.34 | 2.93 | ns | 1.4 | ns | ns | 1.78 | ns | ns | ns | partial 1-IgSF FREP | FREPJ5 |
| Bg28617 | ns | ns | 1.8 | 2.29 | 3.92 | ns | ns | ns | ns | ns | 2.48 | 1-IgSF FREP | FREP2 |
| Bg29167 | ns | ns | -2.3 | ns | ns | ns | ns | ns | ns | ns | ns | partial 1-IgSF FREP | new partial FREP |
| Bg32905* | 6.74 | 5.68 | ns | ns | ns | 1 | ns | ns | ns | 2.75 | ns | partial 2-IgSF FREP | FREPJ1 |
| Bg38205 | ns | -3.62 | -3.69 | 1.28 | 2.62 | 2.29 | ns | ns | ns | ns | ns | partial 1-IgSF FREP | new partial FREP |
| Bg177 | ns | ns | 3.86 | ns | ns | ns | ns | ns | ns | ns | ns | sFReD | |
| Bg178 | ns | ns | 2.79 | ns | ns | ns | ns | ns | ns | ns | ns | sFReD | |
| Bg2450 | ns | 3.1 | ns | ns | ns | ns | ns | ns | ns | ns | ns | sFReD | |
| Bg2494 | ns | ns | -5.03 | ns | ns | ns | ns | ns | ns | ns | -5.69 | sFReD | |
| Bg12039 | -3.93 | -3.43 | ns | ns | ns | ns | ns | ns | ns | ns | ns | partial sFReD | |
| Bg16307 | ns | 4.38 | -4.36 | ns | ns | ns | ns | ns | ns | 4.12 | -7.23 | sFReD | |
| Bg16436 | ns | 1.23 | ns | ns | ns | ns | ns | ns | ns | ns | ns | partial sFReD | |
| Bg17605 | ns | ns | -1.68 | ns | ns | ns | ns | ns | ns | ns | ns | sFReD | |
| Bg18336 | ns | ns | ns | 1.14 | ns | ns | ns | ns | ns | ns | ns | sFReD | za_tig_4714 |
| Bg20351 | ns | ns | ns | 3.46 | 6.59 | 2.98 | ns | ns | ns | ns | ns | sFReD | BgMFREP4_AY012701-like |
| Bg25643 | ns | 1.24 | ns | 1.64 | ns | ns | ns | ns | ns | ns | ns | sFReD | |
| Bg28385 | 5.85 | 5.88 | ns | 2.55 | ns | ns | ns | 3.36 | 3.82 | ns | ns | sFReD | |
| Bg34525 | ns | ns | ns | 1.6 | ns | ns | ns | ns | ns | ns | ns | partial sFReD | |
| Bg37621 | ns | ns | ns | 2.83 | ns | ns | ns | ns | ns | ns | ns | partial sFReD | |
| Bg38723 | ns | ns | ns | ns | ns | ns | ns | ns | ns | ns | -5.61 | sFReD | |
| Bg40034 | 4.55 | 3.82 | 2.06 | ns | 1.11 | ns | ns | ns | ns | ns | ns | partial sFReD | 16_tig_2402_BGLB007591-like |
| Bg40437 | ns | ns | -4.14 | ns | ns | ns | ns | ns | ns | ns | -5.16 | partial FReM | FReM |
Notes:
Value in cells represents the value of log2(fold change) or log2(FC). Any up-regulated gene with log2(FC) ≥1 is highlighted in red, and any down-regulated gene with log2(FC) ≤-1 is highlighted in blue.
0.5d, 2d, 8d, 40d represent the 4 sampling time points. They include time-matched unexposed controls and exposed snails for valid comparisons.
ns: no significant expression difference detected. Gene with PPDE ≥0.95 and FC ≥2 in EBSeq analysis is considered to be differentially expressed in this study.
In the column of “Type of FReD”, B. glabrata FReD proteins were considered “partial” based on the criteria set in this study. “1-IgSF FREP” and “2-IgSF FREP” represent numbers of IgSF domains in a particular FREP.
“Best hit to published FREP” in the last column represents the best hit of the protein against published B. glabrata FREP sequences from available sources [30,32–34]. Any protein sequence identity ≥90% is considered as the same FREP; identity 85~90% is considered as the corresponding FREP “-like”; identity <85% is not assigned to any published FREP. Several FREPs were highlighted in yellow to emphasize in this study.
In the differential expression analysis, SUS unexposed snails were set as baseline for the corresponding time-matched RES unexposed snails at constitutive level; RES unexposed snails were used as baseline for the corresponding time-matched RES snails exposed to S. mansoni; similarly, SUS unexposed snails were used as baseline for the corresponding time-matched SUS snails exposed to S. mansoni.
Fig 8Single nucleotide variant (SNV) analysis in B. glabrata FREPs between SUS and RES with RNA-Seq sequences.
SNV analysis of (A) FREP2 (Bg28617-PA); (B) FREP4 (Bg125-PA); (C) FREP3.1 (Bg96-PA); and (D) FREP3.2 (Bg204-PB). “Ref_BB02”, “SUS”, and “RES” are protein sequences of corresponding FREPs; in which RES and SUS are regenerated based on SNVs in their transcriptome data with BB02 as reference. Four featured sequences of “Signal peptide”, “IgSF1”, “IgSF2” and “FBG” are highlighted in colors. Each SNVs in RES from the two susceptible strains of BB02 and SUS are boxed in red. Any absolute matched sequences to identified peptides from FREP2, FREP3.2 of the plasma of SUS or RES from the pull-down experiments by the Li et al. [47] are framed in gray boxes with solid line. Sequences in FREP3.2 absolutely matched to the two RES-specific peptides from the pull-down experiments by Wu et al. [49] are framed in gray boxes with dash line.